Kubicka S - Search Results

1

Clinical relevance of mutations in the precore genome of the hepatitis B virus.

Tillmann H, Trautwein C, Walker D, Michitaka K, Kubicka S, Böker K, Manns M. Tillmann H, et al. Among authors: kubicka s. Gut. 1995 Oct;37(4):568-73. doi: 10.1136/gut.37.4.568. Gut. 1995. PMID: 7489947 Free PMC article.

2

Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.

Kubicka S, Trautwein C, Schrem H, Tillmann H, Manns M. Kubicka S, et al. J Hepatol. 1995 Oct;23(4):412-9. doi: 10.1016/0168-8278(95)80199-5. J Hepatol. 1995. PMID: 8655958

3

Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.

Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Böker KH, Maschek HJ, Pichlmayr R, Manns MP. Trautwein C, et al. Among authors: kubicka s. Hepatology. 1996 Sep;24(3):482-8. doi: 10.1002/hep.510240303. Hepatology. 1996. PMID: 8781311

4

Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor.

Bock CT, Kubicka S, Manns MP, Trautwein C. Bock CT, et al. Among authors: kubicka s. Hepatology. 1999 Apr;29(4):1236-47. doi: 10.1002/hep.510290426. Hepatology. 1999. PMID: 10094970

5

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.

Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Böker K, Kubicka S, Pastucha L, Stangel W, Manns MP. Tillmann HL, et al. Among authors: kubicka s. Gut. 2001 May;48(5):714-8. doi: 10.1136/gut.48.5.714. Gut. 2001. PMID: 11302974 Free PMC article.

6

Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.

Mundt B, Wirth T, Zender L, Waltemathe M, Trautwein C, Manns MP, Kühnel F, Kubicka S. Mundt B, et al. Among authors: kubicka s. Gut. 2005 Nov;54(11):1590-6. doi: 10.1136/gut.2004.056929. Gut. 2005. PMID: 16227360 Free PMC article.

7

Involvement of TRAIL and its receptors in viral hepatitis.

Mundt B, Kühnel F, Zender L, Paul Y, Tillmann H, Trautwein C, Manns MP, Kubicka S. Mundt B, et al. Among authors: kubicka s. FASEB J. 2003 Jan;17(1):94-6. doi: 10.1096/fj.02-0537fje. Epub 2002 Nov 15. FASEB J. 2003. PMID: 12475902

8

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

Klein C, Bock CT, Wedemeyer H, Wüstefeld T, Locarnini S, Dienes HP, Kubicka S, Manns MP, Trautwein C. Klein C, et al. Among authors: kubicka s. Gastroenterology. 2003 Jul;125(1):9-18. doi: 10.1016/s0016-5085(03)00720-0. Gastroenterology. 2003. PMID: 12851866

9

Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.

Kubicka S, Trautwein C, Niehof M, Manns M. Kubicka S, et al. Hepatology. 1997 Apr;25(4):867-73. doi: 10.1002/hep.510250414. Hepatology. 1997. PMID: 9096590

10

Hepatocellular carcinoma.

Manns MP, Kubicka S. Manns MP, et al. Among authors: kubicka s. Digestion. 1997;58 Suppl 1:69-75. doi: 10.1159/000201532. Digestion. 1997. PMID: 9225098 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters